More tools:Markets·Screener·Research·Chat

Aflac Inc. (AFL) Financial Statements

Aflac Inc.
SIC 6321 · ACCIDENT & HEALTH INSURANCE
FIGI BBG001S5NGJ4
XNYS · usd
115.16▼ 2.05 (-1.75%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close117.21
Day's Range114.87 – 116.78
52-Week Range104.66 – 130.22
Volume2.1M
Avg Volume2.0M
Share Statistics
Shares Outstanding
Employees12.7K
ExchangeXNYS
Listed1973-08-27
Share count as of July 28, 2026
Loading Income Statement…
Key questions about Aflac Inc. (AFL)
What is Aflac Inc.'s Market Cap?
Aflac Inc.'s Market Cap is $57.7B, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s Enterprise Value?
Aflac Inc.'s Enterprise Value is $60.0B, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s Trailing P/E?
Aflac Inc.'s Trailing P/E is 11.9×, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s Price / Sales?
Aflac Inc.'s Price / Sales is 3.2×, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s EV / Revenue?
Aflac Inc.'s EV / Revenue is 3.3×, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s Revenue (TTM)?
Aflac Inc.'s Revenue (TTM) is $18.1B, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s Net Income (TTM)?
Aflac Inc.'s Net Income (TTM) is $4.9B, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s Diluted EPS (TTM)?
Aflac Inc.'s Diluted EPS (TTM) is 9.70, based on as-reported figures from SEC (XBRL) filings.
What is Aflac Inc.'s Net Debt?
Aflac Inc.'s Net Debt is $2.3B, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues:
Net earned premiums, principally supplemental health insurance
Net investment income
Net investment gains (losses)
Other income (loss)
Total revenues
YoY growth-1.0%+27.9%-9.9%+60.7%
Benefits and expenses:
Benefits and claims, excluding reserve remeasurement
Reserve remeasurement (gains) losses
Total benefits and claims, net
Acquisition and operating expenses:
Amortization of deferred policy acquisition costs
Insurance commissions
Insurance and other expenses
Interest expense
Total acquisition and operating expenses
% of revenue30.8%29.7%28.6%27.6%
Total benefits and expenses
Earnings before income taxes
Income taxes
Net earnings
% of revenue20.0%23.4%28.3%34.6%
Net earnings per share:
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted-average outstanding common shares used in computing earnings per share (In thousands):
Cash dividends per share